Freeport-McMoRan Inc. buy BNP Paribas Exane
Start price
17.09.25
/
50%
€38.21
Target price
17.09.26
€47.24
Performance (%)
36.72%
Price
12.02.26
€52.24
Summary
This prediction is currently active. The BUY prediction by BNP_Paribas_Exane for Freeport-McMoRan Inc. has seen massive gains of 36.72%. This prediction currently runs until 17.09.26. The prediction end date can be changed by BNP_Paribas_Exane at any time. BNP_Paribas_Exane has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Freeport-McMoRan Inc. | 3.816% | 3.816% |
| iShares Core DAX® | 1.927% | -2.112% |
| iShares Nasdaq 100 | -0.184% | -5.899% |
| iShares Nikkei 225® | 7.076% | 6.457% |
| iShares S&P 500 | -0.201% | -3.667% |
Comments by BNP_Paribas_Exane for this prediction
In the thread Discuss Freeport-McMoRan Inc.
Freeport-McMoRan (NYSE:FCX) had its price target raised by analysts at BNP Paribas Exane from $52.00 to $56.00. They now have an "outperform" rating on the stock.
Ratings data for FCX provided by MarketBeat
Stopped prediction by BNP_Paribas_Exane for Freeport-McMoRan Inc.
Freeport-McMoRan Inc.
Start price
Target price
Perf. (%)
€39.09
05.12.25
05.12.25
€48.05
05.12.26
05.12.26
33.66%
12.02.26
12.02.26
Freeport-McMoRan Inc.
Start price
Target price
Perf. (%)
€30.87
25.09.25
25.09.25
€44.28
25.09.26
25.09.26
69.23%
12.02.26
12.02.26